Jushi Holdings Inc. Announces Participation at Upcoming Conferences in December 2020

BOCA RATON, Fla., Nov. 20, 2020 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF), a vertically integrated, multi-state cannabis operator, announced that Erich Mauff, President, Board Member and Founder of Jushi, will participate at two upcoming conferences:

  • Cowen Inc.’s 3rd Annual Boston Cannabis Conference is being held on November 30 – December 2, 2020. Mr. Mauff will be participating in virtual one-on-one investor meetings on Tuesday, December 1, 2020.
  • 2020 Cantor Fitzgerald Virtual MSO Cannabis Summit is being held on December 15 – 16, 2020. Mr. Mauff is scheduled to participate in a fireside chat on Wednesday, December 16, 2020 at 11:30am ET.

For more information about the conferences or to schedule a one-on-one meeting with Jushi’s management during these events, please contact Jushi’s Investor Relations at Investors@jushico.com.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry-leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information please visit www.jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-453-1308
Investors@jushico.com

Media Contact:

Ellen Mellody
MATTIO Communications
570-209-2947
Ellen@Mattio.com

Staff

Recent Posts

2026 Payer IT Outsourcing Outlook: Outcome-Based Managed Services, Production-Grade GenAI Governance, and Vendor-Risk Enforcement

Black Book Research Q4 flash survey shows health plans shifting from effort-based sourcing to KPI-backed…

9 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this…

12 hours ago

Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…

12 hours ago

PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements

TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

12 hours ago

MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings

Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec.…

12 hours ago